首页 > 市场调查报告书 > 製药

药物开发临床实验临床开发

市场调查报告书

商品编码

1544198

临床试验用品市场规模、份额和成长分析：按阶段、最终用户、服务、地区 - 产业预测，2024-2031 年

Clinical Trial Supplies Market Size, Share, Growth Analysis, By Phase, By End-user (Pharmaceutical and Biotechnology Companies, Contract Research Organisations ), By Service, By Region - Industry Forecast 2024-2031

出版日期: 2024年08月27日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球临床试验用品市场规模为21亿美元，从2023年的29亿美元增至2031年的45亿美元，预计在预测期内（2024-2031年）复合年增长率为6.5%。

由于全球化程度的提高、临床试验数量的增加以及对生技药品和生物相似药的日益关注等几个关键因素，全球临床试验用品市场正在经历显着增长。为了控制高昂的研发成本并提高业务效率，生物製药公司越来越多地采用先进的供应链管理系统。临床试验用品占整体研发支出的很大一部分，随着生技药品和温度敏感药物试验数量的增加，对专用临床试验设施的需求正在迅速增加。目前，38%的药物需要温度控制，35%的后期药物是生物製药，生物製剂因其比传统药物副作用更少而受到青睐。已开发和发展中地区对生物相似药的需求不断增加，进一步推动了市场发展。发展中国家具有成本优势且易于招募患者，使其成为临床试验的一个有吸引力的地点。亚太地区、拉丁美洲以及中欧和东欧等地区具有经济优势且易于招募病患。例如，在新加坡和中国，政府正在投资生物医学研究，而在拉丁美洲，语言障碍不是问题。此外，由于发展中国家的疾病种类繁多，我们可以支持罕见疾病的临床试验。这些综合因素促进了临床试验用品市场的稳定扩张。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Catalent, Inc.（US）
Thermo Fisher Scientific Inc.（US）
Sharp Packaging Services（US）
CordenPharma（Austria）
Almac Group（UK）
PCI Pharma Services（US）
Eurofins Scientific（Luxembourg）
ICON plc（Ireland）
Biocair International Ltd（UK）
DHL（Germany）
Myoderm（US）
Ancillare LP（US）
Intertek Group plc（UK）
KLIFO A/S（Denmark）
N-SIDE（Belgium）
Sharp Clinical Services（US）
Catalent Pharma Solutions（US）
Woodfield Distribution, LLC（US）
Avantor, Inc.（US）
Worldwide Clinical Trials, Inc.（US）

简介目录

Product Code: SQMIG35D2077

Global Clinical Trial Supplies Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.9 billion in 2023 to USD 4.50 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The global clinical trial supplies market has experienced substantial growth, driven by several key factors including increased globalization, a rise in the number of clinical trials, and a growing focus on biologics and biosimilars. To manage high research and development (R&D) costs and enhance operational efficiency, biopharmaceutical companies are increasingly adopting advanced supply chain management systems. Clinical trial supplies represent a significant portion of overall R&D expenditures, and with the rising number of biologics and temperature-sensitive drugs being tested, the demand for specialized clinical trial facilities has surged. Presently, 38% of pharmaceutical drugs require temperature control, and 35% of late-phase drugs are biologics, which are preferred for their reduced side effects compared to traditional medications. The market growth is further fueled by the increasing demand for biosimilars across both developed and developing regions. Developing countries offer cost advantages and facilitate patient recruitment, making them attractive locations for clinical trials. Regions such as Asia Pacific, Latin America, Central & Eastern Europe, and the Middle East provide economic benefits and ease of patient recruitment. For instance, governments in Singapore and China invest in biomedical research, while in Latin America, language barriers are less of an issue. Additionally, the diverse range of diseases in developing countries supports clinical trials for rare conditions. This combination of factors is contributing to the robust expansion of the clinical trial supplies market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Supplies Market Segmental Analysis

The Global Clinical Trial Supplies market is segmented by phase, application, therapeutic use, type, end user, service and region. Based on phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV. Based on application, the market is segmented into pharmaceutical and biopharmaceutical, and contract research organizations (CROs). Based on therapeutic use, market is segmented into Oncology, immunology, cardiology, genetic diseases, Cardiovascular, Infectious disease, Metabolic disorders, Others. Based on service market is segmented into Manufacturing, Storage & retention, logistics and distribution, packaging, labelling and blinding, comparator sourcing and others. Based on type market is segmented into, Small molecules, biological drugs, medical devices.Based on end-user, it is segmented as Pharmaceutical and Biotechnology Companies, Contract Research Organisations (CRO's), Medical Device Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Clinical Trial Supplies Market

A major driver of the global clinical trial supplies market is the growing demand for specialized drug products, particularly biologics. Biologics are intricate molecules derived from living organisms and used to treat a range of diseases. Due to their complexity, these drugs necessitate specific clinical trial supplies to ensure their safety, efficacy, and stability throughout the research process. Essential supplies for biologics include specialized refrigeration, custom packaging materials, and advanced temperature monitoring systems to maintain their stability during trials. The rising demand for biologics, attributed to their effectiveness and fewer side effects compared to traditional treatments, is significantly fueling the need for these specialized clinical trial supplies.

Restraints in the Global Clinical Trial Supplies Market

A significant challenge for the global clinical trial supplies market is the rising cost of conducting clinical trials. These expenses have surged in recent years, constraining market growth. Furthermore, the complexities of patient recruitment and the stringent regulatory requirements associated with clinical trials further impede market expansion. These factors create barriers for small and mid-sized companies, making it challenging for them to enter and compete in the market. Consequently, the high costs and regulatory hurdles are limiting the overall growth and development of the clinical trial supplies sector.

Market Trends of the Global Clinical Trial Supplies Market

A notable trend in the global clinical trial supplies market is the increasing integration of blockchain technology. Blockchain provides a decentralized, secure, and transparent framework for tracking and managing the clinical trial supply chain, from production through to patient delivery. By offering real-time tracking, blockchain enhances the efficiency of clinical trials, minimizes errors and discrepancies, and strengthens data security. This technology is anticipated to play a growing role in the clinical trial supplies sector, driven by its potential to streamline operations and ensure greater integrity in the supply chain.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Technology Analysis
Pricing Analysis
Supply chain analysis
Patent analysis
Value chain analysis
Case study analysis

Clinical Trial Supplies Market by Service

Logistics & Distribution
Storage & Retention
Packaging, Labelling & Blinding
Manufacturing
Comparator Sourcing
Other Services
- Solutions
- Ancillary supplies

Clinical Trial Supplies Market by Phase

Phase I
Phase II
Phase III
Phase IV
BA/BE Studies

Clinical Trial Supplies Market by Type

Small-Molecules
Biologic Drugs
Medical Devices

Clinical Trial Supplies Market by Therapeutic Area

Oncology
Infectious Diseases
Neurology
Metabolic Disorders
Immunology
Cardiology
Genetic Diseases
Other Therapeutic Areas
- Respiratory Diseases
- Dermatological Conditions
- Rare Diseases
- ENT Diseases
- Nephrology

Clinical Trial Supplies Market by End-user

Pharmaceutical and Biotechnology Companies
Contract Research Organisations (CRO's)
Medical Device Companies

Clinical Trial Supplies Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Catalent, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Packaging Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CordenPharma (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PCI Pharma Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocair International Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DHL (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myoderm (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ancillare LP (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KLIFO A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
N-SIDE (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Clinical Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalent Pharma Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Woodfield Distribution, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worldwide Clinical Trials, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments